Direct antiviral therapy for hepatitis C cirrhotic patients in liver transplantation settings: a systematic review.

Published in: Hepatology international (2022)

DAA therapy for decompensated patients must be personalized with consideration of different factors, particularly among those with MELD scores between the two cutoff-values proposed by the current associational guidelines.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
heart failure
peritoneal dialysis
prognostic factors
patient reported outcomes
hepatitis b virus